University Hospitals Birmingham NHS Foundation Trust

Status Drug name NICE TAs Comments Subchapter
Status: Red Dinoprostone 7.1. Drugs used in obstetrics
Status: Red Dinoprostone (Prostin E2) 7.1. Drugs used in obstetrics
Status: Red Diphenylcyclopropenone in acetone 0.00001-6.0% w/v  (diphencyprone)

Unlicensed special

13.14. Dermatology specials
Status: Green Diprosalic ointment

Potent potency

13.4. Topical corticosteroids
Status: Green Diprosalic scalp application

Potent potency

13.4. Topical corticosteroids
Status: Amber Dipyridamole 2.9. Antiplatelet drugs
Status: Amber Dipyridamole M/R capsules 2.9. Antiplatelet drugs
Status: Red Diroximel fumarate 8.2. Drugs affecting the immune response
Status: Red Disodium edetate 0.37% (EDTA)

For hospital use only

11.8. Miscellaneous ophthalmic preparations
Status: Green Disodium etidronate (Didronel®) 6.6. Drugs affecting bone metabolism

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top